MannKind posted Phase 3 trial results last October, comparing Afrezza in patients aged 4 to 17, with multiple daily insulin ...

Forbes contributors publish independent expert analyses and insights. Juergen Eckhardt leads Bayer’s impact investment unit, Leaps by Bayer. As a venture investor in healthcare, I am privileged to ...

Please provide your email address to receive an email when new articles are posted on . The American Diabetes Association Scientific Sessions featured symposia on novel treatments for diabetes and ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the autoimmune disease.

Add Yahoo as a preferred source to see more of our stories on Google. According to the WHO, more than 800 million people around the world have diabetes, with more than half of them not receiving ...

People with diabetes suffer from depression more frequently than average. Researchers from the German Diabetes Center (DDZ), the Research Institute of the Diabetes Academy Mergentheim ...

Treatment-induced neuropathy of diabetes (TIND) is a rare but potentially painful complication of diabetes caused by high blood sugar and nerve damage. Treatment-induced neuropathy of diabetes (TIND) ...

If you’ve been diagnosed with cancer and you have diabetes, you should know that cancer treatments can have a strong effect on your blood sugar. It can be tricky to navigate the two conditions at the ...

A one-size-fits-all approach may not be the best way to treat albuminuria in patients with diabetes. Multiple guidelines recommend a renin-angiotensin system (RAS) inhibitor (an angiotensin-converting ...

U.S. Sens. Jeanne Shaheen (D-NH) and Susan Collins (R-ME) are introducing new, bipartisan legislation, the Diabetes Interventions Addressing Barriers to Enrollment, Technology and Education Services ...